Nextrials Nominated for World Technology Awards
Nextrials lauded for its work with industry standards organizations to advance integration of clinical trial data collection platforms with electronic health records.
Nextrials Nominated for the World Technology Awards
Nextrials lauded for its work with industry standards organizations to advance integration of clinical trial data collection platforms with electronic health records
San Ramon, CA – April 27, 2009 –
Nextrials, Inc. (www.nextrials.com <
http://www.nextrials.com
> ), a leader in clinical research software and services, today announced that it is a nominee in the World Technology Network’s 2009 World Technology Awards. Since 2000, this award has been presented annually to outstanding science and technology innovators producing work likely to have the greatest long-term significance. Nextrials was singled out for its recent progress toward integrating Prism®, its electronic data capture and clinical trial management platform, with platforms used to manage electronic health records in the healthcare setting.
“On average, it costs over $1 billion to develop a new drug, and up to 12 years to complete the clinical trials process, obtain approvals and deliver the drug to market; as it stands, it is a virtually unsustainable system,” noted James Rogers, co-founder and CEO of Nextrials. “The biopharmaceutical industry has made great strides in eliminating manual, paper-based systems to help alleviate development costs by using electronic data capture and management platforms such as Prism. Now, by achieving the integration of these platforms with those used to maintain electronic patient records, we can revitalize the market through even more savings in labor, cost and time.”
Nextrials was nominated for its contribution to the industry, specifically through participation with industry organizations such as the Clinical Data Interchange Standards Consortium (CDISC) and Integrating the Healthcare Enterprise (IHE), in developing and implementing EDC and EHR integration standards.
“The World Technology Awards program is a very inspiring way to identify and honor the most innovative organizations in the technology world,” said James P. Clark, founder and Chairman of the World Technology Network. “Nextrials’ forward-thinking approach will undoubtedly hold long-term significance to both the pharmaceutical and healthcare industries.”
Nextrials’ award-winning Prism melds sophisticated clinical trial management functionality with electronic data capture in a single, integrated package. It is currently used worldwide by biopharmaceutical and medical device R&D teams developing novel treatments and therapeutics. Visitors to the 18th Annual Partnerships with CROs Conference, being held April 28-30 at the Rosen Shingle Creek Hotel in Orlando, FL, can view a demonstration of Prism in Nextrials’ booth #601.
About The World Technology Network
The World Technology Network is a New York-headquartered organization that was created to "encourage serendipity” - happy accidents - amongst those individuals and companies deemed by their peers to be the most innovative in the science and technology world. The WTN's areas of interest range from IT and communications to biotech, energy, materials, space, as well as related fields such as finance, marketing, policy, law, design, and ethics. For more information, visit
http://www.wtn.net/
.
About Nextrials
Founded by pharmaceutical researchers in 1999, Nextrials offers today’s most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com <
http://www.nextrials.com
> , follow us on Twitter @Nextrials, or call 925-355-3000.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
